Specialized [18F]CFA PET radiotracer of a patient with an extensive solid tumor, measuring dCK activity, both at baseline and after 28 days of treatment at 480 mg/day shows complete target engagement. The dark area in the right image reflects radiotracer excretion via the liver.
Specialized [18F]CFA PET radiotracer of a patient with an extensive solid tumor, measuring dCK activity, both at baseline and after 28 days of treatment at 480 mg/day shows complete target engagement. The dark area in the right image reflects radiotracer excretion via the liver.